LYPRINOL

Serial Number 78166424
Registration 2806625
800

Registration Progress

Application Filed
Sep 20, 2002
Under Examination
Approved for Publication
Oct 8, 2003
Published for Opposition
Oct 28, 2003
Registered
Jan 20, 2004

Trademark Image

LYPRINOL

Basic Information

Serial Number
78166424
Registration Number
2806625
Filing Date
September 20, 2002
Registration Date
January 20, 2004
Published for Opposition
October 28, 2003
Renewal Date
January 20, 2024
Drawing Code
1

Status Summary

Current Status
Active
Status Code
800
Status Date
Apr 4, 2024
Registration
Registered
Classes
005

Rights Holder

Pharmalink International Limited

16
Address
Third Floor, 31 C-D Wyndham Street
Central Hong Kong
HK

Ownership History

Pharmalink International Limited

Original Applicant
16
Central HK

Pharmalink International Limited

Owner at Publication
16
Central HK

Pharmalink International Limited

Original Registrant
16
Central Hong Kong HK

Legal Representation

Attorney
Elizabeth A. Cominolli

USPTO Deadlines

Next Deadline
3008 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 2004-01-20)
Due Date
January 20, 2034
Grace Period Ends
July 20, 2034

Application History

31 events
Date Code Type Description Documents
Apr 4, 2024 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Apr 4, 2024 RNL2 Q REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) Loading...
Apr 4, 2024 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Apr 2, 2024 EROP I TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Loading...
Mar 27, 2024 PR89 O POST REGISTRATION ACTION MAILED - SEC. 8 & 9 Loading...
Mar 27, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Nov 2, 2023 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Jan 20, 2023 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Dec 28, 2013 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Dec 28, 2013 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Dec 28, 2013 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Dec 28, 2013 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Dec 17, 2013 89AF I REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED Loading...
Dec 17, 2013 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Sep 30, 2011 COC. O CORRECTION UNDER SECTION 7 - PROCESSED Loading...
Sep 28, 2011 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Sep 27, 2011 ES7R I TEAS SECTION 7 REQUEST RECEIVED Loading...
Jan 4, 2010 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jan 4, 2010 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Dec 23, 2009 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jan 20, 2004 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 28, 2003 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 8, 2003 NPUB O NOTICE OF PUBLICATION Loading...
Sep 5, 2003 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 27, 2003 CFIT O CASE FILE IN TICRS Loading...
Aug 7, 2003 1.BD I Sec. 1(B) CLAIM DELETED Loading...
Aug 7, 2003 MAIL I PAPER RECEIVED Loading...
Aug 6, 2003 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 15, 2003 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 14, 2003 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 24, 2002 MAIL I PAPER RECEIVED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of inflammatory conditions, namely rheumatoid and osteoarthritis, asthma, psoriasis, colitis, lupus, cardio inflammation, inflammation of limbs resulting from injury; natural medicines containing extracts of shell fish and omega fatty acids, namely, pain relief medication

Additional Information

Other
In the statement, column 1, line 2, " HONG KONG CORPORATION " should be deleted, and, " CAYMAN ISLANDS " should be inserted, and In the statement, column 1, line 3 before the word THIRD, " C/O " should be inserted.

Classification

International Classes
005